In a multi-centre phase III randomized trial comparing Drug X in combination with Prednisone to mitoxantrone and prednisone for advanced hormone refractory prostrate cancer, Quintiles’ knowledge of patient-referral patterns in the selected countries enabled quick identification of key investigators and maximization of referrals to them.